Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 07/26 04:13:36 pm
93.32 EUR   +0.76%
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICID : Industry Study, Insights, Statistics and Research ..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Bayer : 2Q 2016 -- Forecast

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/22/2016 | 05:37pm CEST

FRANKFURT--The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) second-quarter results, based on a poll of 13 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released July 27.

=== 
                                        Net 
                       EBITDA   EBIT attrib.        EPS 
2nd Quarter      Sales   adj.   adj. income   EPS  core 
AVERAGE         12,080  2,940  2,174  1,383  1.65  2.01 
Prev. Year      12,090  2,899  2,088  1,152  1.39  2.00 
+/- in %          -0.1   +1.4   +4.1    +20   +19  +0.4 
 
MEDIAN          12,106  2,932  2,167  1,400  1.68  1.98 
Maximum         12,280  3,024  2,282  1,492  1.75  2.11 
Minimum         11,824  2,845  2,084  1,221  1.48  1.93 
Amount (a)           9      9      6      6     4     8 
 
Baader-Helvea   12,179  3,024     --  1,444  1.75  1.99 
Berenberg       12,106  2,845  2,084  1,221  1.48  1.93 
Commerzbank     12,280  3,000     --     --    --    -- 
Deutsche Bank   12,130     --  2,282  1,437  1.74  2.06 
Equinet         11,824  2,923     --     --    --  2.11 
Exane BNP Par.  11,978  2,982  2,197  1,492    --    -- 
Jefferies       12,109  2,882  2,185     --    --  1.97 
JP Morgan           --  2,926     --     --    --  2.07 
LBBW            12,065  2,950  2,148  1,341  1.62  1.97 
 
            Target price  Rating             DPS 2016 
AVERAGE           106.11  positive 6  AVERAGE    2.71 
Prev. Quarter     125.67  neutral  3  Prev. Year 2.50 
+/- in %             -16  negative 1  +/- in %   +8.4 
 
MEDIAN            105.00              MEDIAN     2.70 
Maximum           124.00              Maximum    2.75 
Minimum            81.00              Minimum    2.65 
Amount                 9              Amount        5 
 
Baader-Helvea      81.00  Sell                     -- 
Bankhaus Lampe    103.00  Buy                    2.75 
Commerzbank       102.00  Buy                      -- 
Deutsche Bank     124.00  Buy                    2.65 
Equinet           118.00  Buy                      -- 
Exane BNP Paribas 105.00  Neutral                2.70 
Jefferies         100.00  Hold                   2.75 
JP Morgan             --  Neutral                  -- 
LBBW              110.00  Buy                    2.70 
NordLB            112.00  Buy                      -- 
=== 

Year-earlier figures are as reported by the company.

(a) Including estimates from analysts who want to remain anonymous.

DJG/mus 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICIDES MARKET 2016 : Industry Study, Insights, Statistics and Researc..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBAYER : Holder Broaches Hostile Monsanto Bid -- WSJ
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20 MONSANTO : Views Bayer's Revised Proposal as Financially Inadequate and Insuffic..
07/20DJMONSANTO : Spurns Sweeter Offer -- WSJ
07/20 COVESTRO : shares ‘Chinese innovation’ with the globe
07/20 BAYER : says Monsanto offer not subject to any financing condition
More news
Sector news : Pharmaceuticals - NEC
03:51p Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
01:45pDJEli Lilly Revenue Rise Helped by New Products
01:40pDJELI LILLY : Revenue Helped by Sales of New Drugs
09:25a Takeda sets bidding deadline for chemical firm stake, CVC and Carlyle may bid..
07/25DJSTADA ARZNEIMITTEL : Feels More Heat From Active Ownership
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
07/20 Bayer investor floats idea of hostile Monsanto bid
07/19 Warren Buffett Finds A Gem
07/19 Bayer investor seeks shareholder vote on Monsanto deal
07/19 REUTERS : Monsanto, Bayer in talks over confidentiality pact
Advertisement
Financials (€)
Sales 2016 47 216 M
EBIT 2016 8 161 M
Net income 2016 4 672 M
Debt 2016 16 060 M
Yield 2016 2,88%
P/E ratio 2016 17,04
P/E ratio 2017 14,42
EV / Sales 2016 1,96x
EV / Sales 2017 1,82x
Capitalization 76 592 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 110 €
Spread / Average Target 18%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Helmut Gunter Wilhelm Panke Member-Supervisory Board
Paul Achleitner Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-20.02%84 345
JOHNSON & JOHNSON21.58%343 528
PFIZER INC.13.94%223 065
NOVARTIS AG-5.13%218 815
ROCHE HOLDING LTD.-9.62%217 668
MERCK & CO., INC.10.87%162 096
More Results